Westminster Pharmaceuticals Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets recall — FDA D-0582-2025
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Overview of recall records associated with Westminster Pharmaceuticals LLC, including dates, categories and classifications where available.
Classification mix: Class II: 2.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
This page summarizes recall records in which the official source identifies Westminster Pharmaceuticals LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.